Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo (CLEAR Outcomes)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02993406
Recruitment Status : Active, not recruiting
First Posted : December 15, 2016
Last Update Posted : September 14, 2021
The Cleveland Clinic
Information provided by (Responsible Party):
Esperion Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2022